First Time Loading...
S

Scientific and Medical Equipment House Company CJSC
SAU:4014

Watchlist Manager
Scientific and Medical Equipment House Company CJSC
SAU:4014
Watchlist
Price: 49.7 SAR -5.51% Market Closed
Updated: May 15, 2024
Section:
 

Relative Value

The Relative Value of one Scientific and Medical Equipment House Company CJSC stock under the Base Case scenario is 55.61 SAR. Compared to the current market price of 49.7 SAR, Scientific and Medical Equipment House Company CJSC is Undervalued by 11%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
55.61 SAR
Undervaluation 11%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

1.9
P/S
P/S
Price to Sales
1.9
vs History
35
vs Industry
51
Median 3Y
1.9
Median 5Y
1.9
Industry
2.4
Forward
1.5
More Details
37.2
P/E
P/E
Price to Earnings
37.2
vs History
39
vs Industry
13
Median 3Y
36
Median 5Y
36
Industry
23.9
Forward
24.4
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
33
Median 3Y
-10.3
Median 5Y
-10.3
Industry
15.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
27
Median 3Y
-26.5
Median 5Y
-26.5
Industry
22.5
More Details
2.9
P/B
P/B
Price to Book Value
2.9
vs History
28
vs Industry
30
Median 3Y
2.9
Median 5Y
2.9
Industry
2.3
More Details
1.9
EV/S
EV/S
Enterprise Value to Sales
1.9
vs History
46
vs Industry
49
Median 3Y
2
Median 5Y
2
Industry
2.5
Forward
1.5
More Details
11.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
11.3
vs History
10
vs Industry
18
Median 3Y
10
Median 5Y
10
Industry
5.3
More Details
16.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
16.5
vs History
57
vs Industry
21
Median 3Y
17.8
Median 5Y
17.8
Industry
12.9
Forward
12.7
More Details
21.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
21.8
vs History
50
vs Industry
21
Median 3Y
23.2
Median 5Y
23.2
Industry
17.8
Forward
17.4
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
31
Median 3Y
-10.4
Median 5Y
-10.4
Industry
15.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
27
Median 3Y
-10.3
Median 5Y
-10.3
Industry
19.6
More Details
1.5
EV/IC
EV/IC
Enterprise Value to IC
1.5
vs History
71
vs Industry
46
Median 3Y
1.9
Median 5Y
1.9
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
Scientific and Medical Equipment House Company CJSC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SA
Scientific and Medical Equipment House Company CJSC
SAU:4014
1.5B SAR 1.9 37.2 16.5 21.8
US
Cigna Group
XMUN:CGN
92.4B EUR 0.5 27.6 9.9 13.1
US
Cigna Corp
NYSE:CI
98.5B USD 0.5 27.2 9.8 13
US
CVS Health Corp
NYSE:CVS
70.1B USD 0.2 9.6 8.7 8.7
US
Laboratory Corporation of America Holdings
NYSE:LH
17.8B USD 1.4 41.1 12.4 18.7
DE
Fresenius SE & Co KGaA
XETRA:FRE
16.1B EUR 0.7 -27.2 10.2 22.9
US
Quest Diagnostics Inc
NYSE:DGX
15.4B USD 1.7 18.3 10.9 14.8
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12B EUR 0.6 24 7 16.7
DE
Fresenius Medical Care AG
XMUN:FME
11.8B EUR 0.6 23.7 7 16.5
US
DaVita Inc
NYSE:DVA
12B USD 1 14.7 8.3 11.9
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.